Being someone not inclined to take medication, I had many doubts, but they took the time to understand my goals, address my concerns, and develop a personalized plan
A separate trial is investigating once-weekly Semaglutide 2.4 mg compared with placebo in obese patients with HFpEF and type 2 diabetes is ongoing
Hypokalemia (low potassium) is a known risk with insulin therapy, especially in medically complex situations
Clinical trials of brand-name tirzepatide showed average weight loss of 20-22%significantly more than the 15% average with GLP-1-only medications
For diabetes, rates are highest among American Indian/Alaska Native adults at 13.6%, followed by Non-Hispanic Black adults at 12.1% and Hispanic adults at 11.7% ^35
Just real food that works with a slowed gut instead of fighting it